Business
REG - Irish Takeover Panel - Disclosure Table
REG - Irish Takeover Panel - Disclosure Table
About this update from Pandox Ab Class B
RNS Number : 7046F Irish Takeover Panel 31 October 2025 IRISH TAKEOVER PANEL Disclosure Table The following companies are deemed to be in an offer period for the purposes of disclosure under the Rules of the Irish Takeover Panel:_______________________________________________________________Offeree: Dalata Hotel Group plcOffer period commenced: 6 March 2025€0.01 ordinary shares; ISIN: IE00BJMZDW83; NSI: 211,483,988Offeror: Pandox Ireland Tuck Limited, a company wholly owned by Pandox AB and Eiendomsspar ASDisclosure of dealings and positions in this offeror is not requiredOfferor identified: 3 June 2025Rule 2.6(a) deadline: N/AOfferee: Mural Oncology plcOffer period commenced: 15 April 2025$0.01 ordinary shares; ISIN: IE000LK2BOB4; NSI: 17,268,881Offeror: XOMA Royalty CorporationDisclosure of dealings and positions in this offeror is not requiredOfferor identified: 20 August 2025Rule 2.6(a) deadline: N/AOfferee: Avadel Pharmaceuticals plcOffer period commenced: 22 October 2025$0.01 ordinary shares; ISIN: IE00BDGMC594; NSI: 97,403,364Offeror: Alkermes plcDisclosure of dealings and positions in this offeror is not requiredOfferor identified: 22 October 2025Rule 2.6(a) deadline: N/AOfferee: Permanent TSB Group Holdings plcOffer period commenced: 30 October 2025€0.01 ordinary shares; ISIN: IE00BWB8X525; NSI: 544,996,176Offeror: N/AOfferor identified: N/ARule 2.6(a) deadline: N/AIrish Takeover Panel 31 October 2025 Lower Ground Floor76 Merrion SquareDublin D02 X4T1Telephone: + 353-1-678 9020 This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END ISEBGBDGBGXDGUB